مرور Volume 13, Issue 2 بر اساس موضوع "Abitant"
در حال نمایش موارد 1 - 1 از 1
-
A Prospective Triple-blind Randomized Trial on Safety and Efficacy of Abitant in the Prevention of Chemotherapy-Induced Nausea and Vomiting
(Tehran, Iranian Blood and Cancer Society, 2021-06-01)Background: Oral Aprepitant, a neurokinin-1 receptor antagonist, is suggested in combination with other antiemetic agents in preventing chemotherapy-induced nausea and vomiting(CINV) associated with emetogenic chemotherapeutic ...



